WNT2 and metastatic malignant neoplasm in the lymph nodes: However, the recurrence rate was 10.8% in patients with high WNT2 expression but in whom lymph node metastasis was not observed, whereas recurrence was investigated in only 2.6% of patients (P < 0.01) in the low WNT2 expression group.